Is NAM cheap yet ?The problem with this stock as a takeover target is its tricky 2 class share scheme. Growers and non-growers. Like AWB.Anyone know why they have fallen ?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025